Lisa H. Butterfield, PhD, is the Vice President of the PICI Research Center, and an Adjunct Professor of Microbiology and Immunology at the University of California, San Francisco. She is focused on cancer vaccines and cellular therapies.
Lisa was most recently Professor of Medicine, Surgery, Immunology and Clinical and Translational Science at the University of Pittsburgh (2003-2018) and Director of the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory. She holds a PhD in Biology from UCLA, followed by postdoctoral fellowships in Cellular Immunology and Cancer Gene Therapy also at UCLA. She is the President of the Society of Immunotherapy of Cancer (SITC, 2017-2018) and a member of the SITC Executive Committee (2015-2020). She led the Immunology Reference Lab for the ECOG-ACRIN NCI cooperative group (2006-2018). She investigates immunotherapy for hepatocellular cancer and melanoma, involving peptides, dendritic cells and adenoviruses, and effector responses to tumor antigens. She has published over 150 peer-reviewed manuscripts, reviews and book chapters, and mentored over 20 students and postdocs.